Abstract
Cryotherapy has been used for years. The prospect of its use in focal therapy has spurred renewed interest in it, which in its recent evolutions enhance both the accuracy and reliability that are especially needed for focal ablation while preserving adjacent tissue. Improvements in thermoimaging monitoring and new percutaneous cryoprobes have resulted in lowering technical limitations and make cryotherapy fit for both primary localized prostate cancer treatment with intention-to-treat and salvage therapy for locally recurrent prostate cancer following radiation therapy.
With acknowledgments to Romain Haider, Damien Ambrosetti, Lisa Camus (photography credits)
Romain Haider, MD, Department of Urology, Hôpital Pasteur 2 - Centre Hospitalier Universitaire de Nice, University of Nice-Sophia-Anitpolis, 3à voie Romaine, 06000, Nice, France
Damien Ambrosetti, MD, PhD, Department of Pathology, Hôpital Pasteur 2 – Centre Hospitalier Universitaire de Nice,University of Nice-Sophia Antipolis, France
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ASTRO:
-
American Society for Therapeutic Radiology and Oncology
- BPH:
-
Benign prostate hyperplasia
- DRE:
-
Digital rectal examination
- EBRT:
-
External beam radiation therapy
- ED:
-
Erectile dysfunction
- HIFU:
-
High-intensity focused ultrasonography
- IQR:
-
Interquartile range
- PCa:
-
Prostate cancer
- TRUS:
-
Transrectal ultrasound
- US:
-
Ultrasound
- VTP:
-
Vascular-targeted photodynamic therapy
References
In the first generation of cryotherapy, Cooper and Lee made the first catheter (1961).
Robilotto AT, et al. Development of a tissue engineered human prostate tumor equivalent for use in the evaluation of cryoablative techniques. Technol Cancer Res Treat. 2007;6(2):81–9.
Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology. 2002;60(2 Suppl 1):40–9.
http://www.cryogenicsociety.org/resources/defining_cryogenics/joule-thomson_effect/.
Tatsutani K, et al. Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. Urology. 1996;48(3):441–7.
Babaian RJ, et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol. 2008;180(5):1993–2004.
Nguyen HD, Allen BJ, Pow-Sang JM. Focal cryotherapy in the treatment of localized prostate cancer. Cancer Control Juill. 2013;20(3):177–80.
Bahn D, de Castro Abreu AL, Gill IS, et al. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. Eur Urol. 2012;62(1):55–63.
Durand M, Barret E, Galiano M, Rozet F, Sanchez-Salas R, Ahallal Y, et al. Focal cryoablation: a treatment option for unilateral low-risk prostate cancer. BJU Int. 2014;113(1):56–64.
Onik G, Vaughan D, Lotenfoe R, et al. The “male lumpectomy”: focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol. 2008;26(5):500–5.
Ellis DS, Manny Jr TB, Rewcastle JC. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results. Urology. 2007;70(6 Suppl 1):S9–15.
Lambert EH, Bolte K, Masson P, Katz AE. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology. 2007;69:1117–20.
Ward JF, Jones JS. Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry. BJU Int. 2012;109(11):1648–54.
Ellis DS, Manny Jr TB, Rewcastle JC. Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation. Urology. 2007;69(2):306–10.
De Castro Abreu AL, Bahn D, Leslie S, Shoji S, Silverman P, Desai MM, et al. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy. BJU Int. 2013;112(3):298–307.
Babaian RJ, Donnelly B, Bahn D, Baust JG, Dineen M, Ellis D, et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol. 2008;180(5):1993–2004.
Onik G, Narayan P, Vaughan D, et al. Focal “nerve-sparing” cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology. 2002;60(1):109–14.
Consensus statement: guidelines for PSA following radiation therapy. American society for therapeutic radiology and oncology consensus panel. Int J Radiat Oncol Biol Phys. 1997;37(5):1035-41.
Pisters LL. Cryotherapy for prostate cancer: ready for prime time? Curr Opin Urol. 2010;20(3):218–22.
Williams SG, et al. An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk. Int J Radiat Oncol Biol Phys. 2006;65(2):351–7.
Villers A, McNeal JE, Freiha FS, Stamey TA. Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer. 1992;70(9):2313–8.
Mayes JM, Mouraviev V, Sun L, Tsivian M, Madden JF, Polascik TJ. Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer? Urol Oncol. 2011;29(2):166–70.
Rosen RC, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319–26.
Barry MJ, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549–57. discussion 1564.
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96.
Caso JR, et al. Complications and postoperative events after cryosurgery for prostate cancer. BJU Int. 2012;109:840–5. http://www.ncbi.nlm.nih.gov/pubmed/21883827.
Eggener SE, Scardino PT, Carroll PR. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol. 2007;178(6):2260–7.
Barret E, Ahallal Y, Sanchez-Salas R, Galiano M, Cosset JM, Validire P, et al. Morbidity of focal therapy in the treatment of localized prostate cancer. Eur Urol. 2013;63:618–22.
Gonder MJ, Soanes WA, Smith V. Experimental prostate cryosurgery. Invest Urol. mai 1964;1:610–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag France
About this chapter
Cite this chapter
Durand, M., Mahate, Z., Wijeratne, V. (2015). Focal Cryotherapy. In: Barret, E., Durand, M. (eds) Technical Aspects of Focal Therapy in Localized Prostate Cancer. Springer, Paris. https://doi.org/10.1007/978-2-8178-0484-2_11
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0484-2_11
Published:
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0483-5
Online ISBN: 978-2-8178-0484-2
eBook Packages: MedicineMedicine (R0)